David M. Knott’s Aurinia Pharmaceuticals AUPH Stock Holding History

David M. Knott’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.39M	Sell	62,896 -101,944	-62%	-$1.62M	0.51%	48
2021 Q2	$2.14M	Buy	164,840 +10,000	+6%	+$127K	0.76%	36
2021 Q1	$2.01M	Sell	154,840 -22,700	-13%	-$329K	0.86%	35
2020 Q4	$2.46M	Buy	177,540 +42,940	+32%	+$625K	1.11%	27
2020 Q3	$1.98M	Buy	134,600 +19,790	+17%	+$287K	1.16%	21
2020 Q2	$1.87M	Buy	114,810 +107,510	+1,473%	+$1.72M	1.02%	27
2020 Q1	$106K	Buy	+7,300	New	+$129K	0.07%	85
2019 Q4	–	Sell	-53,000	Closed	-$283K	–	116
2019 Q3	$283K	Sell	53,000 -5,000	-9%	-$30.3K	0.12%	70
2019 Q2	$382K	Buy	58,000 +5,300	+10%	+$33.8K	0.16%	62
2019 Q1	$343K	Buy	+52,700	New	+$350K	0.14%	67

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

David M. Knott's AUPH Position: Q3 2021 in Review

David M. Knott reduced its Aurinia Pharmaceuticals (AUPH) stake by 62% in Q3 2021, selling an estimated $1.62M and leaving 62,896 shares worth $1.39M. The position accounts for 0.51% of the portfolio, ranked #48.

David M. Knott first reported a position in AUPH in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.46M in Q4 2020. 167 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

David M. Knott held 62,896 shares of Aurinia Pharmaceuticals worth $1.39M as of Q3 2021.
David M. Knott sold 101,944 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $1.62M.
Aurinia Pharmaceuticals made up 0.51% of David M. Knott's portfolio in Q3 2021, its #48 holding.
David M. Knott first reported a position in Aurinia Pharmaceuticals in Q1 2019 and has held it in 10 quarters since.
David M. Knott's Aurinia Pharmaceuticals position peaked at $2.46M in Q4 2020.
167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.